Millions of people trusted genetic testing firm 23andMe with their most sensitive data—now many are asking whether they should delete it as the embattled biotech company files for bankruptcy and searches for a buyer.
On Sunday, 23andMe announced it had filed for Chapter 11 bankruptcy protection in the United States, aiming to facilitate a court-supervised sale process. The filing follows years of financial turmoil, strategic missteps, and a massive data breach that exposed the personal information of nearly 7 million users.
